Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$1.2B
153M shares
52-week range
$4.45 – $13.88
39% from low
Sector
SERVICES-PREPACKAGED SOFTWARE
Exchange
NASDAQ
CS
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
www.certara.comNo one on the platform currently holds CERT.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 354,500 | $2.0M |
| Bridgewater Associatesas of 2025-09-30 | 19,122 | $233.7K |
No one on the platform has traded CERT yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CERT This may be shortable soon. Extremely overvalued with critical negatives: -Missed both top and bottom lines. -No growth whatsoever now nor per their tepid and flat guidance. -Continued bottom line losses. -Negative free cash flow. -Huge and expensive debt. -Most importantly: ruthless competition from dozens of similar companies, or from AI models (Claude) that allow bio-simulation to be produced locally by each biotech company itself without needing CERT's services and programs. -Huge short interest = consensus of poor stock performance. -No prestigious biotech fund is invested.
View on StockTwits ↗$CERT Rejected several times at the 50EMA but holy cow look at that volume. Buyers closed out a great week. Long.
View on StockTwits ↗$BULL $CERT What Caused This Spike?This specific type of late-day trading behavior usually points to two common institutional mechanics rather than retail hype:Market-on-Close (MOC) Institutional Orders: Large mutual funds and index trackers accumulate shares throughout the day but mandate that their final executions take place exactly at the official closing price to minimize tracking error.Short-Covering Into Strength: With short interest sitting exceptionally high on the public float, short sellers who wanted to de-risk ahead of the Friday session likely bought blocks at the close to avoid getting trapped over the weekend.The heavy buying allowed the stock to close strong at $8.13, establishing a solid immediate support shelf after its post-earnings volatility earlier in the week.
View on StockTwits ↗$BULL $CERT Breaking Down the Last 30 Minutes of TradingThe data highlights a clear shift from quiet, baseline algorithmic trading to institutional block orders during the market close:12:30 PM – 12:50 PM (PDT): Trading was extremely quiet. Volume hovered between a tiny 7,700 and 32,500 shares per 5-minute interval, with the stock pinned flat around $8.06 to $8.07.12:55 PM (PDT): Momentum began to turn as a wave of buying absorbed 166,136 shares, pushing the stock price up from $8.09 to $8.13.1:00 PM Closing Candle (PDT): A massive block order hit the tape, executing 2,620,034 shares right at the closing bell. This single 5-minute window accounted for a significant portion of the entire day's market liquidity.
View on StockTwits ↗$BULL $CERT Here's what I found for CERT: there was a massive surge of heavy buying in the final 10 minutes of the trading session today.Intraday transaction logs show that trading volume spiked dramatically right before the closing bell, driving a micro-breakout in Certara's stock price.
View on StockTwits ↗$BULL $CERT Take a look at CERT. A breakout might be around the corner if it go pass $8.20 with 5 million volume traded on that day.
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-8-4-certara-inc-stock/ $CERT Certara Earnings Transcript
View on StockTwits ↗$CERT (-24.1% pre) Certara Non-GAAP EPS of $0.08 misses by $0.01, revenue of $93.3M misses by $4.78M https://ooc.bz/l/109808
View on StockTwits ↗$CERT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.36 down -3500.00% YoY • Reported revenue of $93.27M down -10.81% YoY
View on StockTwits ↗$CERT i entered this today. someone who knows about it can you give me a rundown
View on StockTwits ↗$CERT Coming in at #3 on my short squeeze list. This is the only actionable short squeeze investment, catalyst is FTD closeout on aug 3, earnings the 4th. With nvidia partnership and positive forward guidance coming on earnings. Bought calls at 7.50, aug 21st exp at $7 flat yesterday
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $382M | -8.6% | $0.35 | $0.34–$0.36 | 23.6× | 6 |
| 2027 | $391M | +2.4% | $0.40 | $0.35–$0.41 | 20.6× | 6 |
| 2028 | $416M | +6.2% | $0.44 | $-0.61–$1.14 | 18.5× | 3 |
| 2029 | $441M | +6.0% | $0.51 | $0.49–$0.53 | 16.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $0.09 | $0.08 | -10.4% |
| 2026-05-11 | $0.11 | $0.09 | -18.2% |
| 2026-02-26 | $0.11 | $0.09 | -18.2% |
| 2025-11-06 | $0.11 | $0.14 | +27.3% |
| 2025-08-06 | $0.10 | $0.07 | -30.0% |
| 2025-05-05 | $0.13 | $0.14 | +7.7% |
| 2025-02-26 | $0.13 | $0.15 | +15.4% |
| 2024-11-06 | $0.11 |
| $0.13 |
| +18.2% |
| $1.7B |
| — |
| PGNYProgyny, Inc. | $25.89 | +1.85% | $2.0B | — |
| QDELQuidelOrtho Corporation | $15.09 | +1.75% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry